Lexington, MA, May 16, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation, a leading provider of endoscopic imaging and endosurgical solutions, today announced the commercialization of its two novel endoscopic imaging technologies, CAD EYE®, the company’s AI detection system for endoscopic imaging which enables real-time detection of colonic mucosal lesions during colonoscopy procedures, and SCALE EYE®, a first-of-its-kind imaging technology for measuring colonic lesions.

2024年5月16日，马萨诸塞州列克星敦（环球通讯社）--内镜成像和内窥镜解决方案的领先供应商富士胶片医疗保健美国公司今天宣布其两种新型内镜成像技术CAD EYE®的商业化，CAD EYE®是该公司用于内镜成像的人工智能检测系统，可在结肠镜检查过程中实时检测结肠粘膜病变，SCALE EYE®是第一种用于测量结肠病变的成像技术。

Both technologies will be demonstrated at the 2024 Digestive Disease Week (DDW®) annual conference and exhibition in booth 2829, held May 18-21 in Washington, DC. “Our vision has been laser focused on delivering the best possible endoscopic imaging solutions to meet our customers’ growing needs. Knowing how critical it is for GI physicians to accurately visualize and measure lesions during colonoscopy, we are eager to launch CAD EYE and SCALE EYE,” says Tai Fujita, vice president, Endoscopy Division, FUJIFILM Healthcare Americas Corporation.

这两项技术都将在5月18日至21日于华盛顿特区举行的2024年消化疾病周（DDW®）年度会议和展览上展示。FUJIFILM Healthcare Americas Corporation内窥镜检查部副总裁Tai Fujita表示：“我们的愿景是激光专注于提供尽可能最好的内窥镜成像解决方案，以满足客户不断增长的需求。我们知道胃肠道医生在结肠镜检查过程中准确可视化和测量病变的重要性，因此我们渴望推出CAD EYE和SCALE EYE。”。

“Our team looks forward to demonstrating how Fujifilm’s state-of-the-art endoscopic technologies are offering outstanding levels of image clarity and performance to industry experts and physicians at the upcoming DDW.” Since receiving 510(k) clearance for CAD EYE in March, the technology has been installed at five clinical sites in the U.S., including ASCs, community hospitals, and academic medical centers.  “This system expansion from Fujifilm represents an exciting step forward at a time when quality in colonoscopy is a critical focus across the GI community,” said Jason B.

“我们的团队期待着在即将到来的DDW上展示富士胶片最先进的内窥镜技术如何为行业专家和医生提供出色的图像清晰度和性能。”自3月获得510（k）CAD EYE许可以来，该技术已在美国五个临床站点安装，包括ASC，社区医院和学术医疗中心。JasonB。

Samarasena, MD, gastroenterologist with UCI Health. “Leveraging AI for polyp detection support with CAD EYE, along with the introduction of SCALE EYE, a novel real-time polyp .

医学博士萨马拉塞纳（Samarasena），UCI Health的胃肠病专家。“利用AI对CAD EYE的息肉检测支持，并引入新型实时息肉SCALE EYE。